Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07745725 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase II Study of TollB-001 Tablets in Systemic Sclerosis

Name: A Phase II Study of TollB-001 Tablets in Systemic Sclerosis — clinical trial record (NCT07745725)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 2

SponsorToll Biotech Co. Ltd. (Beijing)

Started2026-08

View on ClinicalTrials.gov ↗

Toll Biotech Co. Ltd. (Beijing)

3 trials monitored

See all monitored trials

Scleroderma

302 trials monitored

See 9 trials at risk

The goal of this Phase II study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of TollB-001 Tablets in adults aged 18 to 70 years (male or female) with systemic sclerosis (SSc).

Trial Details

NCT Number	NCT07745725
Lead Sponsor	Toll Biotech Co. Ltd. (Beijing)
Conditions	Systemic Sclerosis (SSc)
Enrollment	36 participants
Start Date	2026-08
Primary Completion	2027-10 (estimated)
Study Completion	2028-02 (estimated)
Updated on ClinicalTrials.gov	2026-08-04